CMND
NASD Clearmind Medicine Inc.$6.35 ↓ -0.23 (-3.50%) Trading Down from the previous close of $6.58
- YTD change
- -95.61%
- vs 20-day SMA
- -1.36%
- vs 200-day SMA
- -89.61%
Price ranges
Price & Performance
+5.15 (+360.14%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $51,820.80
- CMND is down 96% since the beginning of the year
- CMND is down 100% over the past 12 months
- CMND is down 18% over the past 1 month
- 7% of all CMND investors are betting against CMND
CMND reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +590.2%.
- Previous minute
- +$0.00
- Last hour
- -$0.01
- Last 5 days
- +11.01%
- vs 8-day SMA
- +2.61%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.